BridGene Biosciences Welcomes Nobel Laureate Bruce A. Beutler to Scientific Advisory Board for Drug Innovation BridGene Biosciences has appointed Nobel Prize winner Bruce A. Beutler, M.D. to its Scientific Advisory Board, enhancing its drug discovery efforts for hard-to-treat diseases.

BridGene Biosciences Welcomes Nobel Laureate Bruce A. Beutler to Scientific Advisory Board for Drug Innovation #United_States #San_Jose #BridGene_Biosciences #Bruce_A._Beutler #TLR4

BridGene Biosciences Secures $28 Million to Boost Clinical Trials and Expand Its Drug Development Pipeline BridGene Biosciences has successfully raised $28 million in a Series B+ funding round, aimed at advancing its cancer drug BGC-515 and its innovative drug development approach.

BridGene Biosciences Secures $28 Million to Boost Clinical Trials and Expand Its Drug Development Pipeline #United_States #San_Jose #BridGene_Biosciences #Bayland_Capital #BGC-515